Low Incidence and Mortality by SARS-CoV-2 Infection Among Healthcare Workers in a Health National Center in Mexico: Successful Establishment of an Occupational Medicine Program
Por:
Salazar M.Á., Chavez-Galan L., Castorena-Maldonado A., Mateo-Alonso M., Diaz-Vazquez N.O., Vega-Martínez A.M., Martínez-Orozco J.A., Becerril-Vargas E., Sosa-Gómez F.M., Patiño-Gallegos H., Alonso-Martínez D., López-Segundo E., Vidal F., Velasco-González L.J., Pérez-Pulido S., Santillán-Doherty P., Regalado-Pineda J., Salas-Hernández J., Buendía-Roldán I.
Publicada:
1 ene 2021
Categoría:
Public health, environmental and occupational health
Resumen:
Background: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Healthcare workers (HCWs) constitute a population which is significantly affected by SARS-CoV-2 infection worldwide. In Mexico, the Instituto Nacional de Enfermedades Respiratorias (INER) is the principal national reference of respiratory diseases. Aim: To evaluate the efficiency of the INER-POL-TRAB-COVID19 program to mitigate the SARS-CoV-2 infection risk among the INER-healthcare workers (INER-HCW). Methods: Currently, the INER has 250 beds and 200 respiratory ventilators to support COVID-19 patients in critical condition. On March 1st, 2020, the INER-POL-TRAB-COVID19 program was launched to mitigate the SARS-CoV-2 infection risk among the INER-HCW. Findings: From March 1st to October 1st, 2020, 71.5% of INER-HCWs were tested for SARS-CoV-2 infection, and 77% of them were frontline workers. Among the tested INER-HCWs, 10.4% were positive for SARS-CoV-2 infection. Nonetheless, nosocomial infection represented only 3.8% of the cases and the mortality was null. Fifty-three of INER-HCWs positive to SARS-CoV-2 had a negative test 42–56 days post-diagnosis and were returned to service. Finally, although a change in the PPE implemented on May 11th, 2020, the incidence of SARS-CoV-2 infection was not affected. Conclusion: INER has a lower incidence of HCWs infected with SARS-CoV-2 as compared to the mean of the national report. The implementation of the INER-POL-TRAB-COVID19 program is efficient to decrease the risk of infection among the HCWs. Our findings suggest that the implementation of a similar program at a national level can be helpful to provide a safe environment to HCWs and to prevent the collapse of health institutions. © Copyright © 2021 Salazar, Chavez-Galan, Castorena-Maldonado, Mateo-Alonso, Diaz-Vazquez, Vega-Martínez, Martínez-Orozco, Becerril-Vargas, Sosa-Gómez, Patiño-Gallegos, Alonso-Martínez, López-Segundo, Vidal, Velasco-González, Pérez-Pulido, Santillán-Doherty, Regalado-Pineda, Salas-Hernández and Buendía-Roldán.
Filiaciones:
Salazar M.Á.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Chavez-Galan L.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Castorena-Maldonado A.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Mateo-Alonso M.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Diaz-Vazquez N.O.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Vega-Martínez A.M.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Martínez-Orozco J.A.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Becerril-Vargas E.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Sosa-Gómez F.M.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Patiño-Gallegos H.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Alonso-Martínez D.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
López-Segundo E.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Vidal F.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Velasco-González L.J.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Pérez-Pulido S.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Santillán-Doherty P.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Regalado-Pineda J.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Salas-Hernández J.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Buendía-Roldán I.:
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
Gold
|